Methods of identifying longevity modulators and therapeutic...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S009200

Reexamination Certificate

active

07858327

ABSTRACT:
The present invention is based at least in part on the discovery of a role for the JNK signaling pathway in longevity. In particular, the present inventors have shown that modulation of the c-jun N-terminal kinase (JNK) signaling pathway in an organism, optionally in combination with modulation of the insulin receptor (IR) signaling pathway, can enhance longevity in an organism. Accordingly, the present invention features methods of identifying modulators of longevity in assays featuring organisms and/or cells having either a functional or deregulated JNK signaling pathway and, optionally, a functional or deregulated IR signaling pathway. Also featured is an in vitro method of identifying an agent capable of enhancing longevity featuring an assay composition having a JNK signaling pathway molecule and insulin signaling pathway molecule. Further featured are therapeutic methods for the use of JNK signaling pathway modulators to enhance longevity.

REFERENCES:
patent: 7232897 (2007-06-01), Hotamisligil et al.
patent: WO01/18549 (2001-03-01), None
Ip et al. Current Opinion in Cell Biology. 1998; 10:205-219.
Isobe (Current Genomics, 2000, vol. 1, No. 1. pp. 1-10).
Finkel et al. (Nature. vol. 408. Nov. 9, 2000, pp. 239-247).
Weston et al. Current Opinion in Genetics and Development. 2002;12:14-21.
Weston et al. (Current Opinion in Genetics & Development. 2002, 12:14-21).
Kolodziejczyk et al (Current Biology. Aug. 21, 2001; 11(16): 1278-1282).
Greer et al. (Oncogene. 2005; 24: 7410-7425).
Aguirre et al. (Journal of Biological Chemistry. Mar. 24, 2000; 275(12):9047-9054).
Wolff et al. (Experimental Gerontology. 2006; 41: 894-903).
Villanueva et al. (EMBO 2001; 20(18): 5114-5128).
Kawasaki et al. (EMBO. 1999; 18(13): 3604-3615).
Villanueva et al. (EMBO. 2001; 20(18): 5115-5128).
White (Am J Physiol Endocrinol Metab. 2002; 283: E413-E422).
Cousin et al. (Endocrinology. 2001; 142(1): 229-240).
Henderson et al. (Current Biology. 2001; 11: 1975-1980).
Aguirre, Vincent et al, “The c-Jun NH2-terminal Kinase Promotes Insulin Resistance during Association with Insulin Receptor Substrate-1 and Phosphorylation of Ser307,”The Journal of Biological Chemistry, vol. 275(12):9047-9054 (2000).
Apfeld, Javier et al, “Cell Nonautonomy ofC. elegans daf-2Function in the Regulation of Diapause and Life Span,”Cell, vol. 95:199-210 (1998).
Barsyte, Dalia et al, “Longevity and heavy metal resistance indaf-2andage-1long-lived mutants ofCaenorhabditis elegans,”FASEB J., vol. 15:627-634 (2001).
Byrd, Dana Thyra et al, “UNC-16, a JNK-Signaling Scaffold Protein, Regulates Vesicle Transport inC. elegans,”Neuron, vol. 32:787-800 (2001).
Cavigelli, Martin et al, “Induction ofc-fosexpression through JNK-mediated TCF/Elk-1 phosphorylation,”The EMBO Journal, vol. 14(23):5957-5964 (1995).
Clancy, David J. et al, “Extension of Life-Span by Loss of CHICO, aDrosophilaInsulin Receptor Substrate Protein,”Science, vol. 292:104-106 (2001).
Dérijard, Benoit et al, “Independent Human MAP Kinase Signal Transduction Pathways Defined by MEK and MKK Isoforms,”Science, vol. 267:682-685 (1995).
Dlakić, Mensur, “A new family of putative insulin receptor-like proteins inC. elegans,”Curr. Biol., vol. 12(5):R155-R157 (2002).
Feng, Jinliu et al, “Mitochondrial Electron Transport Is a Key Determinant of Life Span inCaenorhabditis elegans,”Developmental Cell, vol. 1:633-644 (2001).
Friedman, David B. et al, “A Mutation in theage-1Gene inCaenorhabditis elegansLengthens Life and Reduces Hermaphrodite Fertility,”Genetics, vol. 118:75-86 (1988).
Gems, David et al, “Two Pleiotropic Classes ofdaf-2Mutation Affect Larval Arrest, Adult Behavior, Reproduction and Longevity inCaenorhabditis elegans,”Genetics, vol. 150:129-155 (1998).
Gerisch, Birgit et al, “A Hormonal Signaling Pathway InfluencingC. elegansMetabolism, Reproductive Development, and Life Span,”Developmental Cell, vol. 1:841-851 (2001).
Gil, Elad B. et al, “Regulation of the insulin-like developmental pathways ofCaenorhabditis elegansby a homolog of thePTENtumor suppressor gene,”Proc. Natl. Acad. Sci. USA, vol. 96:2925-2930 (1999).
Hirosumi, J. et al. “A central role for JNK in obesity and insulin resistance,”Nature, vol. 420(6913):333-336 (2002).
Holzenberger, M. et al, “IGF-1 receptor regulates lifespan and resistance to oxidative stress in mice,”Nature, vol. 421(6919):182-187 (2003).
Honda, Yoko et al, “Thedaf-2 gene network for longevity regulates oxidative stress resistance and Mn-superoxide dismutase gene expression inCaenorhabditis elegans,”FASEB J., vol. 13:1385-1393(1999).
Jia, Kailiang et al, “DAF-9, a cytochrome P450 regulatingC. eleganslarval development and adult longevity,”Development, vol. 129:221-231 (2002).
Kawasaki, Masato et al, “ACaenorhabditis elegansJNK signal transduction pathway regulates coordinated movement via type-D GABAergic motor neurons,”The EMBO Journal, vol. 18(13):3604-3615 (1999).
Kenyon, Cynthia, “Environmental Factors and Gene Activities That Influence Life Span,”C. Elegans II, Cold Spring Harbor Laboratory Press, Riddle, Donald L. et al, eds., Ch. 28 (1997).
Kido, Yoshiaki et al, “The Insulin Receptor and Its Cellular Targets,”The Journal of Clinical Endocrinology&Metabolism, vol. 86(3):972-979 (2001).
Kimura, K.D. et al, “daf-2, an insulin receptor-like gene that regulates longevity and diapause inCaenorhabditis elegans,”Science, vol. 277(5328):942-946 (1997).
Koga, Makoto et al, “ACaenorhabditis elegansMAP kinase kinase MEK-1, is involved in stress responses,”The EMBO Journal, vol. 19(19):5148-5156 (2000).
Lithgow, G.J. et al, “Stress resistance as a determinate ofC. eleganslifespan,”Mech. Ageing Dev., vol. 123(7):765-771 (2002).
Lithgow, G.J. et al, “Thermotolerance of a long-lived mutant ofCaenorhabditis elegans,”J. Gerontol., vol. 49(6):B270-B276 (1994).
Lithgow, Gordon J. et al, “Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress,”Proc. Natl. Acad. Sci. USA, vol. 92:7540-7544 (1995).
Maehama, Tomohiko et al, “The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate,”The Journal of Biological Chemistry, vol. 273(22):13375-13378 (1998).
Mihaylova, Valia T. et al, “The PTEN tumor suppressor homolog inCaenorhabditis elegansregulates longevity and dauer formation in an insulin receptor-like signaling pathway,”Proc. Natl. Acad. Sci. USA, vol. 96:7427-7432 (1999).
Morris, Jason Z. et al, “A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause inCaenorhabditis elegans,”Nature, vol. 382:536-539 (1996).
Murakami, Shin et al, “A Genetic Pathway Conferring Life Extension and Resistance to UV Stress inCaenorhabditis elegans,”Genetics, vol. 143:1207-1218 (1996).
Ogg, Scott et al, “TheC. elegansPTEN Homolog, DAF-18, Acts in the Insulin Receptor-like Metabolic Signaling Pathway,”Molecular Cell, vol. 2:887-893 (1998).
Paradis, Suzanne et al, “A PDK1 homolog is necessary and sufficient to transduce AGE-1 PI3 kinase signals that regulate diapause inCaenorhabditis elegans,”Genes&Development, vol. 13:1438-1452(1999).
Paradis, Suzanne et al. “Caenorhabditis elegansAkt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor,”Genes&Development, vol. 12:2488-2498 (1998).
Pierce, Sarah B. et al, “Regulation of DAF-2 receptor signaling by human insulin and ins-1, a member of the unusually large and diverseC. elegansinsulin gene family,”Genes&Development, vol. 15:672-686 (2001).
Tatar, M. et al, “Slow aging during insect reproductive diapause: why butterflies, grasshoppers and flies are lik

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods of identifying longevity modulators and therapeutic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods of identifying longevity modulators and therapeutic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of identifying longevity modulators and therapeutic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4161125

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.